The Uganda Cancer Institute has successfully carried out its first-ever bone marrow transplant, marking a significant development in Uganda’s cancer treatment capacity.
The procedure was performed on Mr. Sande Stephen, who had been diagnosed with Multiple Myeloma, a type of blood cancer. According to officials at the institute, the patient is recovering well and is expected to be discharged later this week.
The transplant was conducted by a team of Ugandan specialists led by Dr Clement Okello and Dr Henry Ddungu. Medical staff involved in the procedure described it as a complex process requiring careful coordination, specialized equipment, and trained personnel.
Health experts say the development could reduce the number of Ugandan patients forced to travel abroad for similar treatment, which is often expensive and inaccessible to many.
Bone marrow transplants are commonly used to treat certain blood cancers and other serious conditions affecting the bone marrow.
Officials at the institute noted that the successful procedure reflects growing local capacity in handling advanced cancer treatments. They added that efforts are underway to expand such services to benefit more patients in the future.
The case is being viewed as a milestone for Uganda’s healthcare system, particularly in oncology, where access to specialized care has historically been limited. Mr. Sande’s recovery is expected to provide encouragement to other patients requiring similar treatment.
The institute continues to position itself as a key referral center for cancer care in the region, with ongoing investments in training, infrastructure, and specialized services.